Literature DB >> 7876936

Focal intestinal perforation in the extremely-low-birth-weight infant.

C M Novack1, F Waffarn, J H Sills, T J Pousti, M J Warden, M D Cunningham.   

Abstract

The purposes of this report were to (1) document the clinical and laboratory features of 11 extremely-low-birth-weight (ELBW) infants with focal intestinal perforation and (2) investigate the clinical events possibly associated with these perforations by examining matched pairs of infants with and without focal intestinal perforation. During the study period 173 infants with birth weights between 600 and 1000 gm were admitted to the neonatal intensive care nursery. Eleven of these ELBW infants had focal intestinal perforations and formed the study group. These infants were matched with 11 ELBW infants who did not have intestinal perforations or signs of inflammatory bowel disease. The matched pairs were similar in all respects except for a significantly higher percent increase in blood urea nitrogen level after treatment with indomethacin (Wilcoxon signed-rank test, p < 0.02) in infants with intestinal perforation. At laparotomy the perforations were noted to be focal, often multiple, and on the antimesenteric border of the distal ileum. None of the infants showed clinical, radiographic, or intraoperative findings that were consistent with classifications for necrotizing enterocolitis (NEC). The incidence of focal intestinal perforation in ELBW infants was 6% versus 2% for typical NEC. In addition, four of the 11 infants with intestinal perforation had positive cultures for either Staphylococcus epidermidis or Candida albicans, whereas none of the infants without perforation had positive cultures during the study period (Fisher's exact test, p < 0.09). We conclude that the clinical presentation and the characteristic intestinal lesions in this group of ELBW infants are distinct from those in typical cases of NEC.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7876936

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  7 in total

1.  Intestinal perforation in very preterm neonates: risk factors and outcomes.

Authors:  J Shah; N Singhal; O da Silva; N Rouvinez-Bouali; M Seshia; S K Lee; P S Shah
Journal:  J Perinatol       Date:  2015-04-30       Impact factor: 2.521

2.  Discrepancy between the survival rate and neuropsychological development in postsurgical extremely low-birth-weight infants: a retrospective study over two decades at a single institution.

Authors:  Mitsuru Muto; Koshiro Sugita; Satoshi Ibara; Ryuta Masuya; Makoto Matuskubo; Takafumi Kawano; Yumiko Saruwatari; Seiro Machigashira; Koichi Sakamoto; Kazuhiko Nakame; Shin Shinyama; Motofumi Torikai; Yoshihiro Hayashida; Motoi Mukai; Takamasa Ikee; Ryuichi Shimono; Hiroyuki Noguchi; Satoshi Ieiri
Journal:  Pediatr Surg Int       Date:  2021-01-11       Impact factor: 1.827

3.  Multiple ileal polyps associated with gastrointestinal perforation in a 2-day-old neonate.

Authors:  Kimio Asagiri; Yoshiaki Tanaka; Hiroaki Tanaka; Takahiro Asakawa; Ken Tanigawa; Kenjiro Akiyoshi; Shigeki Hikida; Hiroyoshi Mizote
Journal:  Pediatr Surg Int       Date:  2005-10-21       Impact factor: 1.827

4.  Patent ductus arteriosus and spontaneous intestinal perforation in a cohort of preterm infants.

Authors:  Alessandra Mayer; Gaia Francescato; Nicola Pesenti; Federico Schena; Fabio Mosca
Journal:  J Perinatol       Date:  2022-05-19       Impact factor: 2.521

Review 5.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

6.  Recurrent neonatal gastro-intestinal problems after spontaneous intestinal perforation.

Authors:  M S Drewett; D M Burge
Journal:  Pediatr Surg Int       Date:  2007-09-08       Impact factor: 1.827

7.  Prophylactic indomethacin and intestinal perforation in extremely low birth weight infants.

Authors:  John Kelleher; Ariel A Salas; Ramachandra Bhat; Namasivayam Ambalavanan; Shampa Saha; Barbara J Stoll; Edward F Bell; Michele C Walsh; Abbot R Laptook; Pablo J Sánchez; Seetha Shankaran; Krisa P VanMeurs; Ellen C Hale; Nancy S Newman; M Bethany Ball; Abhik Das; Rosemary D Higgins; Myriam Peralta-Carcelen; Waldemar A Carlo
Journal:  Pediatrics       Date:  2014-10-27       Impact factor: 7.124

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.